[1]
H. S. Jardaq and M. Y. Jamal, “The correlation between CYP2C19 Polymorphisms and recurrent risk in Patients with Ischemic Stroke treated with Clopidogrel in Kurdistan region-Iraq”, Iraqi Journal of Pharmaceutical Sciences , vol. 31, no. 2, pp. 251–259, Dec. 2022, doi: 10.31351/vol31iss2pp251-259.